James Paton

La Cañada Flintridge, CA – November 16: Julie Markfield, gets a flu shot as well as boaster shot Moderna vaccine for COVID19 at Flintridge Pharmacy on Tuesday, Nov. 16, 2021 in La Cañada Flintridge, CA. (Irfan Khan / Los Angeles Times via Getty Images)

GSK’s new vaccine hire looks beyond COVID in quest for next hit: ‘The potential is there to really make a much better flu vaccine’

By James Paton and Bloomberg

A health worker prepares the Pfizer vaccine

Failure to address a global surplus of COVID vaccines raises the risk of new variants emerging, health experts warn

By Josh Wingrove, James Paton, and others

Pfizer COVID-19 vaccine

U.K. to offer Pfizer COVID vaccine to children ages 5 to 11

By James Paton, Deirdre Hipwell, and others

YEREVAN, ARMENIA – OCTOBER 16: Noubar Afeyan speaks at the 2019 Aurora Forum on October 16, 2019 in Yerevan, Armenia. (Photo by Victor Boyko/Getty Images for Aurora Humanitarian Initiative)

Moderna chair says COVID could become flu-like endemic in 2022

By James Paton and Bloomberg

A member of staff wearing PPE processes a student’s Innova lateral flow Covid-19 test, which take 30 minutes to give a result, in the Sports Hall at Park Lane Academy in Halifax, northwest England on March 8, 2021 as schools reopen following the easing of lockdown restrictions. – England prepares to reopen schools to in-class teaching on Monday in the first phase of ending its third coronavirus lockdown. (Photo by Oli SCARFF / AFP) (Photo by OLI SCARFF/AFP via Getty Images)

COVID-19 cases surge in schools as U.K. waits to offer vaccines to adolescents

By Suzi Ring, James Paton, and others

Merck & Co. headquarters in Kenilworth, N.J.

Rich countries’ rush to buy Merck antiviral pill risks leaving poor countries behind in COVID fight—again

By James Paton and Bloomberg

A Health Surveilance Assistant prepares to give a dose of the Malaria Vaccinne into the first recipient on April 23, 2019 at Mitundu Community hospital in Malawi’s capital district of Lilongwe on the first day of the Malaria vaccine implementation pilot programme in Malawi aiming to immunise 120,000 children aged two years and under to assess the effectiveness of the pilot vaccine and whether the delivery process is feasible. – Malawi spearhead today large scale pilot tests for the world’s most advanced experimental malaria vaccine in a bid to prevent the disease that kills hundreds of thousands across Africa each year. After more than three decades in development and almost $1 billion in investment, the cutting-edge trial will be rolled out in Malawi’s capital Lilongwe this week and then in Kenya and Ghana next week. (Photo by AMOS GUMULIRA / AFP) (Photo credit should read AMOS GUMULIRA/AFP via Getty Images)

World Health Organization backs first Malaria vaccine for at-risk children

By James Paton, Joel Leon, and others

ENTEBBE, March 5, 2021 — Photo taken on March 5, 2021 shows AstraZeneca-Oxford vaccines from COVAX vaccine sharing program being unloaded from a plane at Entebbe International Airport, Uganda.<br />
Uganda on Friday received the first batch of COVID-19 vaccines from COVAX facility. (Photo by Hajarah Nalwadda/Xinhua via Getty) (Xinhua/Hajarah Nalwadda via Getty Images)

Global COVID vaccine program Covax falls short of its distribution target

By James Paton and Bloomberg

A teenager receives a dose of Pfizer BioNTech vaccine against the Covid-19 at the Bernard de Ventadour middle school college in Privas, southeastern France, on September 6, 2021. (Photo by PHILIPPE DESMAZES / AFP) (Photo by PHILIPPE DESMAZES/AFP via Getty Images)

Rich countries will soon have over 1 billion COVID vaccine doses they don’t need

By James Paton and Bloomberg

SWITZERLAND – AUGUST 08: Switzerland, Basel, Headquarters of the Swiss chemical and pharmaceutical company F, Hoffmann-La Roche. (Photo by Ulrich Baumgarten via Getty Images)

AC Immune shares surge on Alzheimer’s drug trial results

By Naomi Kresge, James Paton, and others

An Iraqi medic picks an oxygen bottle for a COVID-19 patient at a hospital in the northern Iraqi city of Dohuk, about 260 miles (430 kilometers) northwest of the capital, on July 27, 2021. – More than 1.5 million people have now tested positive and 18,347 have officially died of COVID-19 in Iraq, where the health infrastructure is dilapidated and much of the 40 million population remains sceptical of vaccines. (Photo by SAFIN HAMED / AFP) (Photo by SAFIN HAMED/AFP via Getty Images)

How COVID-19 came raging back in 2021

By James Paton, Robert Langreth, and others

Dominican President Luis Abinader receives the Chinese Sinovac vaccine against COVID-19, two and a half months after the country began to immunize its population against the disease, in Santo Domingo, on May 5, 2021. (Photo by Erika SANTELICES / AFP) (Photo by ERIKA SANTELICES/afp/AFP via Getty Images)

China is filling the global COVID vaccine shortage left by the U.S. and India

By Iain Marlow, Sudhi Ranjan Sen, and others

COVID-19 Vaccine Rollout Begins On Boigu Island

AstraZeneca revises vaccine efficacy down to 76% after criticism of U.S. trial data

By James Paton, Michelle Fay Cortez, and others

WASHINGTON, DC – NOVEMBER 13: Dr. Moncef Slaoui speaks with President Donald J. Trump about “Operation Warp Speed” in the Rose Garden at the White House on Friday, Nov 13, 2020 in Washington, DC. (Photo by Jabin Botsford/The Washington Post via Getty Images)

GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment

By James Paton, Riley Griffin, and others

Artist Luke Jerram with his glass sculpture of the Oxford-AstraZeneca coronavirus vaccine at the Paintworks on February 05, 2021 in Bristol, England. The sculpture, which is one million times larger than the actual vaccine nanoparticle, marks the ten millionth vaccination to be administered in the UK. Five limited editions of the artwork will be sold with all profits going to the global charity Médecins Sans Frontières to help communities heavily impacted by the pandemic. Testing positive for Covid-19 himself in November, Jerram says he is still feeling the effects of the virus. “When I created a sculpture of Covid-19 back in March, little did I know I would later be among those to contract the virus.” (Photo by Finnbarr Webster/Getty Images)

University of Oxford finds AstraZeneca vaccine effective on British variant

By Eric Pfanner, James Paton, and others